Brian Mower

Brian Mower is a certified public accountant with over 20 years of professional finance and executive leadership experience, including 17 years in medical device technology companies. Prior to joining Medibio in April 2017, Mr Mower was vice president, finance and international operations of Torax Medical, a venture capital funded firm, from 2009 to 2017. Mr Mower led Torax from early stage clinical research through regulatory approvals, venture capital fund raising, market development, multiple product launches, sales of its implantable medical devices in 8 countries, and the firm’s recent sale to Johnson & Johnson’s Ethicon division. He also spent 2 years as vice president, finance of Empi, a private equity backed medical device firm, where he helped expand sales and profitability through merger and acquisition integration efforts; 7 years as chief financial officer at Iomed, a medical device and drug delivery technology firm, where he led sales expansion through the launch of innovative iontophoresis technology products and its sale to ReAble Therapeutics; audit and consulting experience in the public accounting firm of KPMG LLP.
Bio last updated 20 Apr 2017

Article Timeline

Access to our data for Brian Mower is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Brian Mower is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 30/11/18

1 year TSR5 year TSR
24thProteomics International Laboratories167%
248thMejority Capital5%-8%
446thTransaction Solutions International-22%-0%
741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Chief Financial Officer (Interim CEO Aug-Nov 2018)
Year started and most recent title


128th↑Transaction Solutions International$2.3m
129th↓Proteomics International Laboratories$2.1m
132nd↓Mejority Capital$2.1m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer